InvestSMART

HeraMED Limited (ASX: HMD) - Announcements

Current share price for HMD : $0.035 0.001 (2.78%)+

ASX company news and announcements for HeraMED Limited (HMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All HeraMED Limited (HMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than HeraMED Limited (HMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for HeraMED Limited (HMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$41 Appendix 4E & Preliminary Final Report 29 Feb 2024 4:52PM $0.018 $0.035 risen by 94.44%
$41 Application for quotation of securities - HMD 28 Feb 2024 11:08AM $0.020 $0.035 risen by 75%
$41 Results of Rights Issue and Placement Update 28 Feb 2024 11:08AM $0.020 $0.035 risen by 75%
$41 Reinstatement to Quotation 28 Feb 2024 9:46AM $0.019 $0.035 risen by 84.21%
$41 Broward Health signs 2 year agreement for rollout HeraCARE 28 Feb 2024 9:46AM $0.019 $0.035 risen by 84.21%
$41 Suspension from Official Quotation 26 Feb 2024 10:25AM $0.019 $0.035 risen by 84.21%
$41 Results of Meeting 23 Feb 2024 4:32PM $0.019 $0.035 risen by 84.21%
$41 Trading Halt 22 Feb 2024 11:19AM $0.019 $0.035 risen by 84.21%
$41 Pause in Trading 22 Feb 2024 11:02AM $0.019 $0.035 risen by 84.21%
$41 Update - Proposed issue of securities - HMD 2 Feb 2024 10:51AM $0.019 $0.035 risen by 84.21%
$41 Extension of Entitlement Offer Closing Date 1 Feb 2024 4:47PM $0.018 $0.035 risen by 94.44%
$41 Quarterly Activities & Cashflow Report 31 Jan 2024 3:29PM $0.019 $0.035 risen by 84.21%
$41 HMD Entitlement Offer - Notification Ineligible Shareholders 29 Jan 2024 10:37AM $0.024 $0.035 risen by 45.83%
$41 Despatch of Rights Issue Offer Materials 29 Jan 2024 10:33AM $0.024 $0.035 risen by 45.83%
$41 Notice of General Meeting/Proxy Form 25 Jan 2024 3:38PM $0.024 $0.035 risen by 45.83%
$41 Notification regarding unquoted securities - HMD 23 Jan 2024 2:46PM $0.021 $0.035 risen by 66.67%
$41 Collaboration signed - leading obstetricians and physician 22 Jan 2024 9:21AM $0.023 $0.035 risen by 52.17%
$41 Non-Renounceable Issue 18 Jan 2024 9:35AM $0.025 $0.035 risen by 40%
$41 Proposed issue of securities - HMD 18 Jan 2024 9:29AM $0.025 $0.035 risen by 40%
$41 Cleansing Notice 18 Jan 2024 9:25AM $0.025 $0.035 risen by 40%
$41 Final Director's Interest Notice Emily Slade 17 Jan 2024 9:48AM $0.024 $0.035 risen by 45.83%
$41 Non-Executive Director Resignation 17 Jan 2024 9:41AM $0.024 $0.035 risen by 45.83%
$41 Strategic collaboration and commercial agreement with GPEx 16 Jan 2024 8:25AM $0.023 $0.035 risen by 52.17%
$41 Cleansing Notice 22 Dec 2023 10:24AM $0.026 $0.035 risen by 34.62%
$41 Application for quotation of securities - HMD 22 Dec 2023 10:00AM $0.026 $0.035 risen by 34.62%

176 - 200 of 538 results

Page 8 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.